Duseja AK - Search Results

1

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.

Younossi ZM, Yilmaz Y, Yu ML, Wai-Sun Wong V, Fernandez MC, Isakov VA, Duseja AK, Mendez-Sanchez N, Eguchi Y, Bugianesi E, Burra P, George J, Fan JG, Papatheodoridis GV, Chan WK, Alswat K, Saeed HS, Singal AK, Romero-Gomez M, Gordon SC, Roberts SK, El Kassas M, Kugelmas M, Ong JP, Alqahtani S, Ziayee M, Lam B, Younossi I, Racila A, Henry L, Stepanova M; Global NASH Council. Younossi ZM, et al. Among authors: duseja ak. Clin Gastroenterol Hepatol. 2022 Oct;20(10):2296-2306.e6. doi: 10.1016/j.cgh.2021.11.004. Epub 2021 Nov 9. Clin Gastroenterol Hepatol. 2022. PMID: 34768009 Free article.

2

Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis--is it Gilbert's syndrome?

Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A. Duseja A, et al. Trop Gastroenterol. 2005 Jul-Sep;26(3):123-5. Trop Gastroenterol. 2005. PMID: 16512459

3

The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West.

Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, Kalra N. Duseja A, et al. Dig Dis Sci. 2007 Sep;52(9):2368-74. doi: 10.1007/s10620-006-9136-y. Epub 2007 Apr 10. Dig Dis Sci. 2007. PMID: 17420951

4

Nonalcoholic fatty liver disease in India--is it different?

Duseja A. Duseja A. Trop Gastroenterol. 2006 Oct-Dec;27(4):142-6. Trop Gastroenterol. 2006. PMID: 17542290 Review.

5

Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India.

Dhillon BK, Das R, Garewal G, Chawla Y, Dhiman RK, Das A, Duseja A, Chandak GR. Dhillon BK, et al. World J Gastroenterol. 2007 Jun 7;13(21):2956-9. doi: 10.3748/wjg.v13.i21.2956. World J Gastroenterol. 2007. PMID: 17589946 Free PMC article.

6

Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease.

Duseja A, Thumburu KK, Das A, Dhiman RK, Chawla YK, Bhadada S, Bhansali A. Duseja A, et al. Indian J Gastroenterol. 2007 Jul-Aug;26(4):170-3. Indian J Gastroenterol. 2007. PMID: 17986744

7

Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.

Duseja A, Das A, Dhiman RK, Chawla YK, Thumburu KT, Bhadada S, Bhansali A. Duseja A, et al. Ann Hepatol. 2007 Oct-Dec;6(4):222-6. Ann Hepatol. 2007. PMID: 18007551 Free article. Clinical Trial.

8

Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

Kalra N, Duseja A, Das A, Dhiman RK, Virmani V, Chawla Y, Singh P, Khandelwal N. Kalra N, et al. Ann Hepatol. 2009 Jan-Mar;8(1):21-5. Ann Hepatol. 2009. PMID: 19221529 Free article.

9

Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Duseja A. Duseja A. Indian J Gastroenterol. 2010 Nov;29(6):217-25. doi: 10.1007/s12664-010-0069-1. Epub 2010 Dec 30. Indian J Gastroenterol. 2010. PMID: 21191681 Review.

10

Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).

Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Choudhary NS, et al. Ann Hepatol. 2012 Jul-Aug;11(4):478-86. Ann Hepatol. 2012. PMID: 22700629 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters